AllDocs -> cancers

(continued on next page) Ovarian cancer : Strong family history calls for evaluation By Carl Buccellato, M.D., Bon Secours Cottage Health Services There are various types of cancers that develop and spread without many symp- toms. Ovarian cancer is one of those silent adversaries, which is why as many as 80 percent of cases are not diagnosed until the cancer has reached an advanced stage. It is the second most common gynecologic cancer in women, yet it has the highest mortality rate. No more than 30 percent of patients survive five years after being diagnosed. Researchers are uncertain what causes ovarian cancer in women, but over time have identified some risk factors for devel- oping the disease. Medical studies suggest that women who breastfeed for longer durations are at decreased risk while women who have never been pregnant ...

Last revised: 10/11/2005 UM Comprehensive Cancer Center Patient Education Document #0036 Nov05 Ed. Online version: http://www. cancer .med.umich.edu/learn/percpathways.htm University of Michigan Comprehensive Cancer Center Patient Education Resource Center (PERC) INFORMATION GUIDE Ovarian Cancer The purpose of this information guide is to help patients newly diagnosed with ovarian cancer and their families to find sources of information and support. This list is not meant to be comprehensive, but rather to provide starting points for information seeking. The materials can be found at the Patient Education Resource Center (PERC) of the University of Michigan Comprehensive Cancer Center in room B1-361. Brochures Available free at the Patient Education Resource Center on Level B-1 • National Cancer Institute. What You Need ...

Ovarian Cancer Information © copyright 2005 U-M Comprehensive Cancer Center The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site. Use of the UMHS web site does not replace medical consultation with a qualified health or medical professional to meet the health and medical needs of you or others. While the content of the UMHS web site is frequently updated, medical information changes rapidly and therefore, some information may be out of date, and/or contain inaccuracies or typographical errors. The ovaries are a woman's reproductive organs which produce steroid hormones as well as eggs, called ova. Ovarian cancer usually occurs after menopause. In fact, 50% of ovarian tumors occur in women aged 40 to 60 and 40% over age 60. ...

A FREE Course for all ovarian cancer survivors, friends, family members and others who are interested in hearing from the leading U.S. experts in ovarian cancer research. These experts will share new information about ovarian cancer ,and time for questions and answers will be provided. Saturday, January 21, 2006 12:00 p.m. – 1:00 p.m. Registration 1:00 p.m. – 7:00 p.m. Course Refreshments will be provided during the Break and Networking Reception Moores UCSD Cancer Center Lee and Frank Goldberg Auditorium 3855 Health Sciences Drive La Jolla, CA 92093 www.thegcf.org www.wcn.org cancer .ucsd.edu 200 6 2 0 0 6 Ovarian Cancer Survivors Course 2 0 0 6 Ovarian Cancer Survivors Course This Course is being sponsored by the Gynecologic Cancer Foundation in ...

F R E Q U E N T LY A S K E D Q U E S T I O N S WomensHealth.gov 1-800-994-9662 TDD: 1-888-220-5446 cer. Most cases occur in women over Ovarian Cancer the age of 50, but this disease can also affect younger women. Ovarian cancer causes more deaths than any other can- Q: What is ovarian cancer ? cer of the female reproductive system. A: Cancer is a disease in which certain The sooner ovarian cancer is found and treated, the better a woman’s chance for body cells don’t function right, divide recovery. But ovarian cancer is hard to very fast, and produce too much tissue detect early. Many times, women with that forms a tumor. Ovarian cancer is ovarian cancer have no symptoms or cancer in the ovaries, the female repro- just mild ...

NOTES Pacific Ovarian Cancer Research Consortium Physician Advisory Committee Meeting May 15, 2004 The annual Pacific Ovarian Cancer Research Consortium (POCRC) Physician Advisory Committee Meeting was held on Saturday, May 15, 2004, on the Day Campus of the Fred Hutchinson Cancer Research Center. Dr. Nicole Urban, Principal Investigator of the Consortium, opened the meeting with a consortium overview and a discussion of the vital role of the community physician in the consortium. The agenda included updates of a number of ongoing consortium research studies and a preview of upcoming studies. Background In September 1999, the National Cancer Institute awarded a SPORE (Specialized Program of Research Excellence – organ specific) grant to the Fred Hutchinson Cancer Research Center. The grant funds interdisciplinary, multi-institutional, translational research in ovarian cancer . The ...

To find out more about ovarian cancer go to http://ovariancancer.jhmi.edu It is time we stop the loss of mothers, sisters, daughters, wives and girlfriends from ovarian cancer so I have decided to do something about it. On February 25 – 26, 2006, I will be climbing in the HERA Ovarian Cancer Climb for Life in Las Vegas. I will be climbing in recognition of my friend Sean Patrick who has been fighting this disease for 7 years and for all of the women battling this disease and the 25,500 women who will be newly diagnosed this year. Can I count on your support? The money raised will go directly to support research for early detection of ovarian cancer and new directions in treatment and to aide women and their families battling this disease as well as to support awareness and wellness programs. On the research front, our most pressing task is to develop a reliable early detection test for ovarian cancer ...

Corporate Medical Policy Bone Marrow Transplant for Epithelial Ovarian Cancer File Name: bone_marrow_transplant_for_epithelial_ovarian_cancer Policy Number: SUR6090.10 Origination: 2/2001 Last Review: 11/2004 Next Review: 11/2006 Description of Procedure or Service This policy addresses high-dose chemotherapy with hematopoietic stem-cell support as a treatment of epi- thelial ovarian cancer . Bone marrow transplants typically include high-dose chemotherapy (HDC). "High-dose chemotherapy" (HDC) involves the administration of cytotoxic agents for the treatment of can- cer. It uses doses several times greater than the standard therapeutic dose. In some cases, whole body or localized radiotherapy is also given and is included in the term HDC. The rationale for HDC is that many cytotoxic agents act according to a steep dose-response curve ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com Ovarian Cancer and Exposure to Ionizing Radiation 1 Ovarian Cancer and Exposure to Ionizing Radiation Summary : There has been moderately strong evidence recorded of a possible connection between ovarian cancer and exposure to ionizing radiation. This possible connection is supported by evidence from studies conducted at Los Alamos National Laboratory and other studies of nuclear workers at other sites who have been exposed to ionizing radiation. The National Research Council’s has determined that there is evidence among atomic bomb survivors of ovarian cancer in connection with exposure to ionizing radiation. Ovarian cancers are designated as “specified” cancers under the Energy Employees Occupational Illness Compensation Program Act. Historically, ...

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer File Name: genetic_testing_for_breast_and_ovarian_cancer Policy Number: MED1170 Origination: 8/1997 Last Review: 9/2005 Next Review: 9/2007 Description of Procedure or Service Genetic testing for breast and/or ovarian cancer is used to detect genetic mutations of the BRCA1 and the BRCA2 gene. This test is used for a patient who may be predisposed to breast and/or ovarian cancer through heredity . Families at risk of having hereditary breast and/or ovarian cancer may exhibit the following characteristics: ? breast or ovarian cancer occurs at an early age; ? breast or ovarian cancer occurs in multiple generations; ? breast or ovarian cancer often appears bilaterally (both breasts or both ovaries); ...

Summary of Recommendation The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for ovarian cancer . D recommendation. The USPSTF found fair evidence that screening with serum CA-125 level or transvaginal ultrasound can detect ovarian cancer at an earlier stage than it can be detected in the absence of screening; however, the USPSTF found fair evidence that earlier detection would likely have a small effect, at best, on mortality from ovarian cancer . Because of the low prevalence of ovarian cancer and the invasive nature of diagnostic testing after a positive screening test, there is fair evidence that screening could likely lead to important harms. The USPSTF concluded that the potential harms outweigh the potential benefits. Clinical Considerations • There is no existing evidence that any screening ...

Background In 1996, the USPSTF stated that routine screening for ovarian cancer by ultrasound, the measurement of serum tumor markers, or pelvic examination was not recommended (D recommendation). 1 There was insufficient evidence to recommend for or against the screening of asymptomatic women at increased risk for developing ovarian cancer (C recommendation). In addition, the USPSTF indicated that although there was no direct evidence from prospective studies that women with early-stage ovarian cancer detected through screening have lower mortality from ovarian cancer than do women with more advanced disease, indirect evidence supported this rationale. Available screening tests, however, were found to be inadequately sensitive/specific for screening and had not been adequately tested for this purpose. Epidemiology Ovarian ...

May 25, 2000 Addendum to the Fiscal Year 2000 (FY00) Ovarian Cancer Research Program (OCRP) Announcement This addendum has been provided to address questions about the Program Project Award mechanism. Program Project Awards are one of two funding mechanisms offered by the Department of Defense (DOD) OCRP for FY00. One of the goals of the Program Project Award mechanism is to enhance ovarian cancer research infrastructure. To extend infrastructure to a greater number of institutions, the OCRP Integration Panel (IP), consisting of experts from academic and non-DOD government institutions, has expressed a strong interest in recommending for funding those scientifically meritorious proposals from institutions that do not have active DOD or National Cancer Institute (NCI) program project-type grants for ovarian cancer research at the release date of the FY00 Program Announcement. Specifically, ...

159 Burden of Suffering Ovarian cancer is the fifth leading cause of cancer deaths among U.S. women and has the highest mortality of any of the gynecologic cancers. 1 It accounted for an estimated 26,600 new cases and 14,500 deaths in 1995. 1 The lifetime risk of dying from ovarian cancer is 1.1%. 1a The overall 5-year survival rate is at least 75% if the cancer is confined to the ovaries and de- creases to 17% in women diagnosed with distant metastases. 2,3 Symptoms usually do not become apparent until the tumor compresses or invades ad- jacent structures, ascites develops, or metastases become clinically evi- dent. 4 As a result, two thirds of women with ovarian cancer have advanced (Stage III or IV) disease at the time of diagnosis. 2,5,6 Carcinoma of the ovary is most common in women over age ...

2005 estimate 2004 2000 2001 2003 2002 Fiscal Year Millions of Dollar s $65.5M 0 20 40 60 80 100 120 i $76.9M $93.5M $99.4M $99.5M $100.0M Incidence and Mortality Rate Trends Ovarian cancer accounts for approximately 4 percent of all women’s cancers and is the fourth leading cause of cancer -related death among women in the United States. The incidence rate for ovarian cancer has been slowly declining since the early 1990s. Ovarian cancer has the highest mortality of all cancers of the female reproductive system, which reflects, in part, a lack of early symptoms and proven ovarian cancer screening tests. Thus, ovarian cancer is often diagnosed at an advanced stage, after the cancer ...

Ovarian Cancer Product Guide Provided by Page 2 If you are diagnosed with ovarian cancer , you are not alone. More than 22,000 women are diagnosed with ovarian cancer each year. To ease the burden of this diagnosis on each and every woman, the Gynecologic Cancer Foundation has collected information about various ovarian cancer organizations, and created this guide as a simple and concise resource of available support. A network of support. Where there’s knowledge, there’s hope Inside the guide, you will find a list of national organizations that provides information and products related to ovarian cancer . Please select the materials you would like to receive, place a postage stamp on each card, and mail it to the specific organization. Within three weeks, you should receive the requested information from that organization. For ...

O varian cancer is the second most common gyneco- logic malignancy in the United States and, unfortunately, the most deadly. Ovarian cancer kills more women each year than all other gyneco- logic malignancies com- bined. This year it is esti- mated that approximately 24,000 new cases of ovari- an cancer will be diag- nosed and approximately 14,000 deaths will result from the disease. One of the reasons for the high fatal- ity rate is that more than 70% of women with ovarian cancer are diagnosed with advanced-stage disease. Five-year survival rates for women with disease in ad- vanced stages are only 20% to 30%; however, for those diagnosed when disease is confined to the ovary, cure rates are approximately 90%. 1 Although screening for ovarian cancer in the gener- al population is not yet feasible, it is important for ...

OVACOME FACTSHEET 14 The Staging of Ovarian Cancer What are the stages of ovarian cancer ? This factsheet explains the different stages of ovarian cancer and the reasons for this classification. Included are some comments about treatment for each stage. Cancer of the ovary spreads in two main ways. The most common is along the surface of the lining of the abdomen (the peritoneum) and bowel. Eventually the cancer spreads to involve the layer of fat inside the abdomen (the omentum) and the outside of the liver. The other frequent direction of spread is within the circulation of lymph fluid in the body which is important for immunity (the lymph system). The lymph from the ovaries goes initially to lymph nodes (glands) on the wall of the pelvis (pelvic lymph nodes) and then to lymph nodes around the aorta (para-aortic lymph nodes). ...

OVACOME FACTSHEET 18 Screening for Ovarian Cancer Why may screening for ovarian cancer be important? Early stage ovarian cancer confined to the ovaries (stage I) has an extremely good outlook and can be successfully treated. Unfortunately most ovarian cancers are not recognised at an early stage for a number of reasons. First, cancer of the ovary usually develops after the menopause when the ovaries are inactive and abnormal function of the ovary is not therefore readily noticed. Second, the ovaries are located deep inside the pelvis are inaccessible to examination. Finally, even when symptoms do occur they are usually vague, non-specific symptoms which could be due to a host of other causes. For these reasons by the time most women with ovarian cancer develop symptoms and their cancer is detected it has spread outside the ...

OVACOME FACTSHEET 25 An Overview of Ovarian Cancer This factsheet sets out the different types of ovarian cancer , their characteristics and treatment differences where they exist. It is meant as a resource for readers who remain confused about this complicated issue. Ovarian cancer is classified into different types on the basis of its histological appearance - that is, how it looks to the pathologist down the microscope. The majority of ovarian cancers fall within the category of epithelial ovarian cancer . The remaining 90% consist of rare. Epithelial Ovarian Cancer The greatest clinical challenge of the gynaecological cancers. Approximately 6800 new cases are diagnosed annually and this figure is rising. In the UK the overall 5-year survival is around 28%. Optimists like me hope this figure is also rising. Three-quarters present with ...

OVACOME FACTSHEET 13 The Role of Radiotherapy in Ovarian Cancer What is radiotherapy Radiotherapy is the use of ionising radiation in the treatment of disease. As radiation passes through tissue it collides with atoms along its path. Energy is deposited and utilised by molecules to inflict damage to the DNA of a cell. If this damage is not repaired death of the cell may occur. Normal tissues usually have better repair mechanisms than tumour cells which allow them a better degree of protection. How is radiotherapy delivered This can be done in two ways. External beam radiotherapy accounts for the majority of treatments given and is where radiation is produced from a machine and delivered to the target area from the outside, for example x-rays produced by a linear accelerator. Before treatment can be given a process of planning has to be undertaken. ...

OVACOME FACTSHEET 12 Ovarian Cancer and Your Sexuality As a Specialist Nurse supporting women of all ages who are living with a diagnosis of ovarian cancer , I am faced with the reality of the wider issues which potentially affect them. This factsheet covers the complex area of sexuality. Although this is important to all, it may be called into question suddenly and sometimes quite dramatically when a woman is living with the effects of ovarian cancer . Therefore it is an important area for discussion, but sadly, in my experience, it is often ignored. Women may find that they are not always given time or space to address how their sexuality is being affected; they are often too embarrassed to talk about it or bring it to the attention of healthcare professionals, and consequently may suffer in silence. Healthcare professionals, in turn, may lack the confidence ...

36 TRACKING A LADY KILLER: OVARIAN CANCER SILENT by Scott Still “I’m sorry, but the test came back positive. You have ovarian cancer .” These are among the most dreaded words a woman may hear from her doctor. However, the best chance of beating this affliction, which accounts for four percent of all cancers among women and ranks fifth among female cancer -related deaths, is obtaining this diagnosis as early as possible in the development of the disease; early detection is crucial to improving chances of survival. Page 2 Dr. Michael Tainsky and Dr. Sorin Draghici. Page 3 This is why the research that Wayne State University’s Dr. Michael Tainsky is doing is so critical. The work of Dr. Tainsky and his interdisciplinary team at the Barbara Ann Karmanos Cancer Institute draws upon ...

Chapter 9 Summary Page 2 Summary Ovarian cancer is the most lethal cause of death among the gynecological cancers. Conventional therapies of surgery and chemotherapy failed to significantly improve the survival rates for this disease. Therefore novel therapeutic approaches are needed. Ovarian cancer is a result of accumulation of genetic alterations. This and specific disease features such as confinement of the disease mostly to peritoneal cavity makes gene therapy an attractive and feasible approach. This thesis describes novel gene therapy approaches for the treatment of ovarian cancer . First, Chapter 1 reviews various gene therapy strategies developed for ovarian cancer , such as mutation compensation (including siRNA), molecular chemotherapy, genetic immunopotentiation, and recent approaches of anti-angiogenesis and virotherapy. This chapter also describes ...

2005 Ovarian Cancer Survivor Course September 10, 2005 1 “What is Ovarian Cancer ?”(Clinical and Biological Features of Ovarian Cancer ), Julian Schink, MD 2 “Screening and Early Detection,” Barbara Goff, MD 3 “Update on Clinical Trials,” David Mutch, MD 4 Panel Discussion 5 “New Drugs and the Future Treatment of Ovarian Cancer ,” Robert Coleman, MD 6 “Gene Therapy and Other Targeted Biologic Therapies,” Ronald Alvarez, MD 7 “Complementary Medicine and Quality of Life Issues,” Vivian von Gruenigen, MD 8 “Sexuality and Ovarian Cancer ,” Evelyn Larrison, RN, BSN 9 Advocacy and Legislative Update / Panel Discussion 11 “Genetic Aspects of Ovarian Cancer ,” Diljeet K. Singh, MD, DrPH 12 “The Effects of Surgical Effort on Ovarian Cancer Outcomes,” William Cliby, MD 13 “No More Sleepless Nights: Understanding and Treating Sleep Disturbances in Cancer ...

Chapter 2 Aim of the thesis Page 2 80 Page 3 Aim of the thesis Ovarian cancer affects approximately 1 in 75 women in the developed world and is the predominant cause of mortality from gynecological cancers. Owing to the lack of early, effective screening tools and lack of specific symptoms associated with early stage disease, approximately 70% patients with ovarian cancer are diagnosed at advanced stages. Despite the advancements in surgical debulking and chemotherapy, majority of the patients relapse and ultimately succumb to this disease. The long-term 5-year survival rate is less than 20% for this disease. Thus new therapeutic approaches are needed. Since ovarian cancer is considered to be the result of multiple genetic alterations, gene therapy is emerging as a novel therapeutic option in the treatment of ovarian cancer ...

What Should I Look For? Cancer of the ovaries is very hard to find. There may be no signs or symptoms until the cancer has spread. Things you may feel or see about your body may not seem as if they are connected to cancer . These signs usually are not caused by cancer , but you should report any of the following signs to your doctor right away: Bloating or swelling in the stomach from extra fluids. This swelling is different than what you might feel when you are having your monthly period; Weight gain or loss without any reason; Enlargement in the size of the stomach area; Bleeding or other discharge from your vagina (not your normal period); Stomach problems that do not go away. You might have pain, gas, or nausea; Back or leg pain. What Adds to My Risk? Risks that add to your chance of getting cancer of the ovaries include: Being ...

Kuv Yuav Ceev Faj Txog Yam Dabtsi? Tus kabmob kheesxaws zes qe menyuam (ovaries) nrhiav tau nyuaj kawg nkaus. Ntau zaus yuav tsis muaj yam qhia hais tias muaj mob txog thaum uas tus kabmob twb huam mus thoob ib ce lawm. Ntau yam uas koj mloog tau los txawv txav yuav tsis qhia hais tias koj mob kheesxaws. Tej yam li hauv qab no yuav tsis yog yam qhia hais tias mob kheesxaws, tabsis yog koj muaj koj yuav tsum qhia rau koj tus kws khomob sai li sai tau: Tsam plab los yog plab o los si su tuaj vim muaj kua los dej ntau nyob hauv. Qhov so tuaj no nws tsi yog zoo li thaum koj coj khaub ncaws es koj muaj; Koj qhov hnyav nce los yog poob yam koj tsis paub hais tias vim li cas; Ib ncig ntawm koj lub plab loj tuaj. Los ntshav los yog lwm yam los ntawm koj qhov chaw mos los (uas tsis yog koj coj khaub ncaws); Lwm yam teebmeem nyob hauv koj lub plab uas tsi txawj zoo xws li mob ...

1 QuickTime™ and a Photo - JPEG decompressor are needed to see this picture. Study Reveals Shocking Statistics Regarding Women and Ovarian Cancer Most Women Cannot Identify Symptoms and Know Little About the Deadly Cancer Toronto, September 7, 2005 œ A Decima Research study released today by the National Ovarian Cancer Association (NOCA) uncovers disturbing facts regarding women‘s knowledge of ovarian cancer , the most fatal of gynecologic cancers and a disease that kills over 60% of those diagnosed. These results are announced in the beginning of September as part of National Ovarian Cancer Month. Of the women surveyed, 96% could not identify a combination of the most common symptoms of ovarian cancer . This finding is particularly worrisome because there is no screening test for the early detection of ovarian cancer , and women and their physicians ...

OVARIAN CANCER What You Need To Know About The sooner ovarian cancer is found and treated, the better a woman’s chance for recovery. But ovarian cancer is hard to detect early. Many times, women with ovarian cancer have no symptoms or just mild symptoms until the disease is in an advanced stage. There are many types of tumors that can start in the ovaries. Ovarian cysts are examples of other growths that can occur on the ovaries. Most ovarian cysts are not cancerous. They are fluid-filled sacs that form on the surface of the ovary. Cysts usually go away without treatment, but a doctor may recommend removal, especially if it seems to be growing, to ensure that they do not become cancerous. • About 1 in every 57 women in the United States will develop ovarian cancer . Most cases occur in women over the age of 50, but this disease can also affect younger women. WHO’S AT RISK ...